Epidemiology of Dyslipidemia Among Adult Population of Bangladesh

Rokshana Rabeya 1 , 2 , Mohammad Hayatun Nabi 2 , Ariful Bari Chowdhury 2 , Sanjana Zaman 2 , Mohammad Niaz Morshed Khan 3  and Mohammad Delwer Hossain Hawlader 2
  • 1 Department of Public Health Nutrition, Primeasia University, Dhaka, Bangladesh
  • 2 Department of Public Health, North South University (NSU), Dhaka, Bangladesh
  • 3 Department of Public Health, State University of Bangladesh, Dhaka, Bangladesh

Abstract

Background and aims: evatedEl level serum of lipids stimulate atherosclerosis, which is the risk factor for stroke, peripheral vascular taeohrrratrrocvtra disease. The aim of this study was to explore the pattern and associated factors of dyslipidemia among Bangladeshi adult population.

Material and methods: A descriptive cross-sectional study was conducted at the outpatient department (OPD) of four Medical College Hospitals, Bangladesh. 200 adults aged 20 to 65 years diagnosed case of dyslipidemia were randomly selected. Fasting CHO, HDL, LDL and TG were measured. According to the criteria of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III), dyslipidemia was classified into (a) Hyper-lipidemia: TC>200 mg/dl, TG>150 mg/dl, (b) Hyper cholesterolemia: TC>200 mg/dl, (c) Hyper-triglyceridemia: TG>150 mg/dl, and (d) Atherogenic-dyslipidemia: TG>150 mg/dl, LDLC>165 mg/dl.

Results: Study found 46% hyperlipidemia, 37% atherogenic dyslipidemia, 13.5% hypercholesterolemia and only 3.5% hypertriglyceridemia. BMI, FBS and HDL-C were significantly higher among female compare to male (p=<0.01, <0.01 and 0.04 respectively). TC and TG were significantly higher among higher calorie intake group in compare to normal intake group (p=0.04).

Conclusions: Results of this study concluded that hyperlipidemia and atherogenic dyslipidemia are common and female dyslipidemic patients are susceptible to develop higher BMI, FBS, and HDL-C.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. World Health Organization. The atlas of heart disease and stroke / Judith Mackay and George Mensah; with Shanthi Mendis and Kurt Greenland. Geneva: World Health Organization 2004. http://www.who.int/iris/handle/10665/43007 (accessed on 12th October 2018)

  • 2. Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease. J Am Coll Cardiol 55(13):1283-1299, 2010.

  • 3. Smith S, Lall AM. A Study on lipid profile levels of diabetics and non-diabetics among Naini region of Allahabad, India. Turkish J Biochem 33(4):138–141, 2008.

  • 4. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atherosclerosis 196(2): 489–496, 2008.

  • 5. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 102(10S):1K–34K, 2008.

  • 6. Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Kim KS, et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham offspring study. Am J Cardiol 94:1561–1563, 2004.

  • 7. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple risk factor intervention trial research group. Arch Intern Med 152(1): 56–64, 1992

  • 8. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of diseases, part 1: general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation 104(22): 2746-2753, 2001.

  • 9. Farzadfar F, Finucane MM, Danaei G. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaborating Group (Cholesterol) National, regional and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377(9765): 578–586, 2011.

  • 10. Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies. Atherosclerosis 203(2): 331–345, 2009.

  • 11. Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: An analysis from the INTERHEART Study. J Am Coll Cardiol 53(3): 244–253, 2009.

  • 12. Bakesiima R, Byakika-Kibwika P, Tumwine JK et al. Dyslipidaemias in women using hormonal contraceptives: a cross sectional study in Mulago Hospital Family Planning Clinic, Kampala, Uganda. BMJ Open 8(10): e022338, 2018.

  • 13. World Health Organization. Global status report on non-communicable diseases 2010, Geneva. Accessed at: https://www.who.int/nmh/publications/ncd_report_full_en.pdf

  • 14. Heng DM, Lee J, Chew SK, Tan BY, Hughes K, Chia KS. Incidence of ischemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore Cardiovascular Cohort Study. Ann Acad Med Singapore 29(2): 231–236, 2000.

  • 15. Reddy KS. Cardiovascular diseases in non-Western countries. N Engl J Med 350(24): 2438-2440, 2004.

  • 16. Li Qi, Xianbin D, Wenge T, Qin Li, Deqiang M, Yulin W. Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing, China. Int. J. Environ. Res. Public Health 12(10): 13455-13465, 2015.

  • 17. Bener A, Mohammad AG, Ismail AN, Zirie M, Abdullatef WK, Al-Hamaq AO. Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population. Bosn J Basic Med Sci 10(3): 210-217, 2010.

  • 18. Li Y, Zhao L, Yu D, Ding G. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. PLoS One 13(10): e0205709, 2011.

  • 19. Cai L, Zhang L, Liu A, Li S, Wang P. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb 19(2): 159–168, 2011.

  • 20. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H. Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One 6(3), 2011.

  • 21. Sharma U, Kishore J, Garg A, Anand T, Chakraborty M, Lali P. Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol 7(6): 653–660, 2013.

  • 22. Gupta R, Ravinder S. Rao, Misra A, Samin K. Sharma. Recent trends in epidemiology of dyslipidemias in India. Indian Heart Journal 69(3): 382-392, 2017.

  • 23. Bayram F, Kocer D, Gundogan K, Kaya A, Demir O, Coskun R et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol 8(2): 206–216, 2014.

  • 24. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc 73(10): 969–976, 1998.

  • 25. Misra A and Shrivastava U. Obesity and Dyslipidemia in South Asians. Nutrients 5(7): 2708–2733, 2013.

  • 26. Gebel Erika. A matter of the sexes: the differences between men and women with diabetes. Diabetes Forecast 64(10): 46-49, 2011.

  • 27. Hillier TA, Pedula KL. Characteristics of an Adult Population with Newly Diagnosed Type 2 Diabetes. The relation of obesity and age of onset. Diabetes care 24(9): 1522–1527, 2001.

OPEN ACCESS

Journal + Issues

Search